Cargando…
Pathologic Response of Associated Ductal Carcinoma In Situ to Neoadjuvant Systemic Therapy: A Systematic Review
SIMPLE SUMMARY: Traditionally, the presence of ductal carcinoma in situ (DCIS) with invasive breast cancer meant that the patient may require complete removal of the breast in order to completely remove the disease. Recently there has been some evidence to the contrary. In this article, we have revi...
Autores principales: | Wazir, Umar, Patani, Neill, Balalaa, Nahed, Mokbel, Kefah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817531/ https://www.ncbi.nlm.nih.gov/pubmed/36612009 http://dx.doi.org/10.3390/cancers15010013 |
Ejemplares similares
-
Ductal Carcinoma In Situ: Recent Advances and Future Prospects
por: Lambert, Kelly, et al.
Publicado: (2012) -
Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled Analysis
por: Alamoodi, Munaser, et al.
Publicado: (2023) -
The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review
por: Tayeh, Salim, et al.
Publicado: (2021) -
Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review
por: Wazir, Umar, et al.
Publicado: (2016) -
Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer
por: Patani, Neill, et al.
Publicado: (2011)